P

Inventor

CHORVAT ROBERT JOHN

US11 patents
⚠️ This page may combine multiple inventors who share the name “CHORVAT ROBERT JOHN”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

DU PONT PHARM CO

7 patents
US6107301AAug 22, 2000

1N-alkyl-N-arylpyrimidinamines and derivatives thereof

DU PONT PHARM CO192 citations97
US6342503B1Jan 29, 2002

1N-alkyl-n-arylpyrimidinamines and derivatives thereof

DU PONT PHARM CO144 citations95
US6124289ASep 26, 2000

Azolo triazines and pyrimidines

DU PONT PHARM CO57 citations95
US6258809B1Jul 10, 2001

6-aryloxy and arylthiopurines

DU PONT PHARM CO21 citations92
US6124300ASep 26, 2000

Aryloxy- and arylthio- fused pyridines and pyrimidines and derivatives

DU PONT PHARM CO32 citations92
US6107300AAug 22, 2000

Arylamino fused pyrimidines

DU PONT PHARM CO35 citations92
US6326368B1Dec 4, 2001

Aryloxy- and arylthiosubstituted pyrimidines and triazines and derivatives thereof

DU PONT PHARM CO11 citations73

BRISTOL MYERS SQUIBB PHARMA CO

1 patent
US6448261B1Sep 10, 2002

Arylamino fused pyridines

BRISTOL MYERS SQUIBB PHARMA CO55 citations95

JENRIN DISCOVERY INC

1 patent
US7482470B2Jan 27, 2009

Cannabinoid receptor antagonists/inverse agonists useful for treating metabolic disorders, including obesity and diabetes

JENRIN DISCOVERY INC21 citations90

BRISTOL MYERS SQUIBB PHARMA

1 patent
US6818648B2Nov 16, 2004

Aryloxy- and arylthiosubstituted pyrimidines and triazines and derivatives thereof

BRISTOL MYERS SQUIBB PHARMA3 citations61

JENRIN DISCOVERY

1 patent
US8680131B2Mar 25, 2014

Cannabinoid receptor antagonists/inverse agonists useful for treating disease conditions, including metabolic disorders and cancers

JENRIN DISCOVERY2 citations60